Glial fibrillary acidic protein expression alters astrocytic chemokine release and protects mice from cuprizone-induced demyelination

Glia
Nadine KramannWolfgang Brück

Abstract

Enhanced glial fibrillary acidic protein (GFAP) expression occurs in most diseases of the central nervous system. Thus far, little is known about the effect that GFAP exerts on astrocyte cell signaling. In the present study, we observed that silencing GFAP expression in isolated astrocytes leads to enhanced CCL2 and CXCL10 release, whereas overexpression of GFAP in astrocytes results in a significantly reduced CXCL10 release in vitro. Additionally, we analyzed transgenic mice carrying a full-length copy of the wild-type human GFAP gene. We demonstrate that a persistent GFAP increase alters the astrocytic cell signaling profile, thereby protecting oligodendrocytes, myelin and, subsequently, axons from cuprizone-induced demyelination. Our study revealed that reduced CXCL10 mRNA was accompanied by reduced NF-κB expression in astrocytes. Furthermore, analysis of human tissue from a patient with Alexander disease showed NF-κB activation in astrocytes to be almost completely absent. Our findings indicate that regulation of GFAP expression in astrocytes is crucial for astrocyte signaling and function. Understanding the role of the cytoskeletal protein, GFAP is thus of importance as it is highly regulated in diseases of the central ner...Continue Reading

References

Jul 1, 1994·Brain Pathology·L F Eng, R S Ghirnikar
Jan 23, 1999·Journal of Neuroimmunology·M M HiremathG K Matsushima
Nov 4, 2000·Neurochemical Research·L F EngY L Lee
Aug 15, 2002·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Rong LiMichael Brenner
Apr 28, 2004·The American Journal of Pathology·Jeffrey L MasonGlenn K Matsushima
Mar 2, 2006·The American Journal of Pathology·Rujin TianJames E Goldman
Aug 28, 2007·The Journal of Comparative Neurology·Alain R Simard, Serge Rivest
Jun 3, 2008·Cellular and Molecular Life Sciences : CMLS·A NairS D Miller
Oct 1, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·David A Rempe, Maiken Nedergaard
Jan 12, 2011·Progress in Neurobiology·J Middeldorp, E M Hol
Aug 19, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Fuzheng GuoDavid Pleasure
Jul 7, 2012·Acta Neuropathologica·Wolfgang BrückChristiane Wegner
Dec 26, 2012·Brain : a Journal of Neurology·Thomas SkripuletzMartin Stangel
Apr 26, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alexander A SosunovJames E Goldman
Apr 3, 2014·PloS One·Sung S ChoiSeung U Kim
Mar 1, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tim ClarnerMarkus Kipp
Aug 25, 2015·Acta Neuropathologica·Markel OlabarriaJames E Goldman
May 22, 2017·Trends in Neurosciences·Heather D E BoothRichard Wade-Martins
Jun 6, 2017·Trends in Neurosciences·Baljit S KhakhRosemarie Grantyn
Nov 21, 2017·Stem Cell Reports·Minna OksanenJari Koistinaho

❮ Previous
Next ❯

Citations

Jul 11, 2020·Cellular and Molecular Life Sciences : CMLS·Inge L WerkmanWia Baron
Mar 18, 2020·Frontiers in Cellular Neuroscience·Remi RonzanoAnne Desmazieres
Oct 28, 2019·Frontiers in Neuroscience·Natallia MakaravaIlia V Baskakov
Aug 28, 2021·Cells·Theresa Greiner, Markus Kipp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.